Pharma Boardroom
PharmaBoardroom is a UK-based B2B content and insights platform for the global pharmaceutical and life sciences industry, distributing country reports, executive interviews, legal handbooks, and statistical data products to a 26,000+ member community of senior decision-makers across 100+ countries via subscription and individual report sales.
- Company typePrivate
- Founded2012
- HeadquartersNorwich, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Pharma Boardroom does
PharmaBoardroom is a B2B content and insights platform serving senior decision-makers in the global pharmaceutical and life sciences industry. Headquartered in Norwich, United Kingdom and operating as PharmaBoardroom Limited (a UK private limited company), the platform distributes country-specific market intelligence, exclusive executive interviews, legal/regulatory handbooks, and statistical data products to a community of 26,000+ decision-makers, over half of whom are C-level executives. The company is led by CEO and Publisher Diana Viola and maintains regional leadership across EMEA, Asia, and the Americas.
The company's core products include Country Reports (multi-region pharma market analyses), In Conversation interviews with CEOs and policymakers, Articles, The Pharma Legal Handbook (country-specific legal and regulatory guides co-developed with leading national law firms), Market Access & HTA Reports, the InFigures statistical data and rankings product, and InFocus thematic e-books. The platform runs on a WordPress publishing stack (pharmaboardroom.com) with a gated membership wall, supplemented by a Shopify e-commerce storefront (pharmaboardroom.myshopify.com) for individual report and e-book purchases. Distribution is driven by weekly email newsletters, LinkedIn, and the proprietary web platform.
PharmaBoardroom generates revenue through two primary streams: recurring paid subscriptions/memberships granting access to gated premium content, and one-time perpetual licenses for individual country reports, legal handbooks, and e-books priced at GBP 75-149 per item. The co-publishing model with 11+ leading national law firms (including Baker McKenzie, Nishimura & Asahi, Fangda Partners, TGS Baltic, ABNR, and others) is a structural feature of content production, particularly for legal/regulatory handbooks across jurisdictions in Europe, Asia-Pacific, the Americas, and the Middle East & Africa. The company has been operating for over two decades, with no disclosed external funding, no parent company, and no evidence of institutional or venture capital ownership.
Pharma Boardroom firmographics
Firmographics- Name
- Pharma Boardroom
- Legal name
- PharmaBoardroom Limited
- Website
- https://pharmaboardroom.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PharmaBoardroom is a UK-based B2B content and insights platform for the global pharmaceutical and life sciences industry, distributing country reports, executive interviews, legal handbooks, and statistical data products to a 26,000+ member community of senior decision-makers across 100+ countries via subscription and individual report sales.
- Ownership category
- akta.pro rank
Pharma Boardroom industry classification
Industry- Product category
- Pharmaceutical Market Intelligence
- NAICS
- Newspaper, Periodical, Book, and Directory Publishers (5131), Book Publishers (513130), Directory and Mailing List Publishers (513140)
- SIC
- Books: Publishing Or Publishing & Printing (2731)
- akta.pro primary industry
- Pricing Operations & Analytics (Price Governance, Systems, Reporting) (HLAIAKAK)
Keywords
Where Pharma Boardroom is headquartered
LocationHeadquarters
- HQ city
- Norwich
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Pharma Boardroom business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others, Technology or R&D
Revenue model
- Subscription Membership: The company operates a membership-based model where users must register and sign in to access premium content including reports, interviews, and articles. The registration form indicates subscription terms with automatic renewal at the end of each subscription period.
- Report Sales: PharmaBoardroom sells country-specific reports, legal handbooks, and e-books through their Shopify-powered shop. Reports include Country Reports, The Pharma Legal Handbook series, and InFocus e-books covering topics like China biotech catalysts, rare diseases, and regional healthcare trends. Prices range from GBP 75-149 for legal handbooks.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Pharma Legal Handbook Country Reports - Individual country legal guides |
| One time/ perpetual license | Pay-as-you-go | Market Access & HTA Country Reports |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Pharma Boardroom product offering
Product offeringCore offering
PharmaBoardroom produces and sells subscription-based market intelligence for the global pharmaceutical and life sciences industry. Its portfolio includes Country Reports, exclusive executive interviews, The Pharma Legal Handbook series, Market Access & HTA Reports, InFigures statistical datasets, and InFocus e-books covering therapeutic areas and regional market trends across 100+ countries. Premium content is gated behind paid membership, with individual reports and handbooks also sold via a Shopify storefront.
Product overview
PharmaBoardroom is a content and insights platform for the healthcare and life sciences industry, offering a portfolio of content products including Country Reports (country-specific pharmaceutical market analyses), Interviews (exclusive conversations with industry leaders), Articles (news and analysis), The Pharma Legal Handbook (legal and regulatory guides), Market Access & HTA Reports (reimbursement and pricing information), InFigures (statistical data and rankings), InFocus (in-depth e-books), White Papers, and Contributions (opinion content). The platform operates on a subscription model providing access to premium reports and exclusive content to its community of over 26,000 decision-makers, including C-level executives, across the global pharmaceutical industry.
Differentiator
Problem solved
Functional benefit
Products and services
- Country Reports Comprehensive country-specific reports covering pharmaceutical markets, healthcare systems, and life sciences industries across the Americas, Asia-Pacific, Europe, and Middle East & Africa, targeted at pharma, biotech, and healthcare decision-makers.
- The Pharma Legal Handbook Comprehensive country-specific legal and regulatory guides covering pharmaceutical law, pricing, reimbursement, marketing, manufacturing, patents, and clinical trial requirements, co-developed with leading national law firms and sold individually (GBP 75-149).
- Market Access & HTA Reports Country-specific market access and health technology assessment guides covering pricing systems, reimbursement frameworks, managed entry agreements, and healthcare system structures, targeted at market access and HEOR professionals.
- InFigures Statistical data and rankings including market data, company rankings, regulatory statistics, and pharmaceutical industry metrics across global markets.
- InFocus (E-books) In-depth focused reports and e-books on specific therapeutic areas, technologies, and regional market trends including cell & gene therapy, precision medicine, rare diseases, and China biotech catalysts.
- Subscription/Membership Paid annual membership providing access to full reports, downloads, exclusive content, and newsletter subscriptions, with automatic renewal at the end of each subscription period.
Companies that use Pharma Boardroom
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Pharma Boardroom technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pharma Boardroom partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core.
- BDK Advokati (Serbia)coreLegal handbook content partnership. BDK Advokati, a leading Serbian law firm, co-prepared The Pharma Legal Handbook: Serbia, answering questions about legal and regulatory environment for pharmaceuticals in Serbia including regulation, pricing, clinical trials, marketing, manufacturing, trademarks and patents.
- TEGOS (Baltic Region)coreLegal handbook content partnership. TEGOS, a leading Baltic law firm, co-prepared The Pharma Legal Handbook: Asia Growth & Transition Market covering Estonia, Latvia and Lithuania, addressing regulation, pricing, clinical and preclinical trials, marketing, manufacturing, trademarks and patents.
- PRK Partners (Slovakia & Czech Republic)coreLegal handbook content partnership. PRK Partners, a leading Czech and Slovak law firm, co-prepared The Pharma Legal Handbooks for Slovakia and Czech Republic, covering regulation, pricing, clinical trials, marketing, manufacturing, trademarks, patents, medical cannabis and opioids.
- Mușat & Asociații (Romania)coreLegal handbook content partnership. Mușat & Asociații, one of Romania's leading corporate law firms, co-developed the Pharma Legal Handbook: Market Access & HTA Romania, a comprehensive country-specific market access and health technology assessment guide.
- ABNR (Indonesia)coreLegal handbook content partnership. ABNR, a leading Indonesian law firm, co-prepared The Pharma Legal Handbook: Asia Growth & Transition Market covering Indonesia.
- Youssry Saleh Law Firm (Saudi Arabia)coreLegal handbook content partnership. Youssry Saleh Law Firm, a leading Saudi Arabia law firm, co-prepared the Market Access & Health Technology Assessment: Saudi Arabia guide.
- Nishimura & Asahi (Japan)coreLegal handbook content partnership. Nishimura & Asahi, a leading Japanese law firm, co-prepared the Market Access & Health Technology Assessment: Japan guide.
- Trench Rossi e Watanabe (Brazil)coreLegal handbook content partnership. Trench Rossi e Watanabe, a leading Brazilian law firm, co-prepared the Market Access & Health Technology Assessment: Brazil guide.
- Baker McKenzie (Italy)coreLegal handbook content partnership. Baker McKenzie, a leading Italian law firm, co-prepared the Market Access & Health Technology Assessment: Italy guide.
- Fangda Partners (China)coreLegal handbook content partnership. Fangda Partners, a leading Chinese law firm, contributed regulatory content including preclinical and clinical trial requirements, product liability, healthcare system and funding, regulatory reforms, and localization information for China.
- TGS Baltic (Baltics)coreLegal handbook content partnership. TGS Baltic, a leading Baltic law firm, co-prepared The Pharma Legal Handbook: Baltics covering Estonia, Latvia and Lithuania.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Pharma Boardroom competitors and assessment
Company assessmentBroad incumbents
- FiercePharma: FiercePharma is a leading B2B news and analysis outlet for the pharma industry, covering drug commercialization, market access, and policy. It overlaps directly with PharmaBoardroom's editorial remit and global audience, but operates at much larger scale and is part of a broader healthcare B2B portfolio.
- Citeline (Informa Pharma Intelligence): Citeline, part of Informa Pharma Intelligence, is a large pharma intelligence provider offering databases, analytics, and reports on drug development, clinical trials, and market access. It is a much larger incumbent that addresses a similar buyer need - global pharma market and regulatory intelligence - but via paid data platforms rather than editorial content.
- GlobalData Healthcare: GlobalData Healthcare provides market intelligence, country reports, and analytics across pharma, biotech, and medtech. It is a direct competitor in the country-specific pharma intelligence segment where PharmaBoardroom sells Country Reports and Market Access & HTA guides, though GlobalData operates at significantly larger scale.
- The Pink Sheet (Citeline): The Pink Sheet is a flagship pharma policy, regulatory, and market access publication now under Citeline/Informa. It is highly comparable to PharmaBoardroom's Pharma Legal Handbook and Market Access & HTA products in content and buyer, but operates as a subscription news service at much larger scale.
- Pharma Intelligence / Scrip: Scrip is a long-established pharma industry news and analysis brand under Citeline/Informa, covering global drug development, commercial strategy, and policy. It competes for the same pharma executive readership as PharmaBoardroom, but at much larger institutional scale.
Direct peers
- BioPharma Dive: BioPharma Dive is a B2B digital publication providing in-depth news and analysis on the biopharma industry, including commercial, regulatory, and R&D coverage. It serves the same C-suite and decision-maker audience as PharmaBoardroom and follows a similar digital-first, subscription-supported model.
- Endpoints News: Endpoints News is a B2B publication focused on the biopharma industry with deep reporting, editorial analysis, and subscriber-supported business model. It targets similar senior industry professionals and competes for the same pharma executive attention as PharmaBoardroom.
- PharmaTimes: PharmaTimes is a long-running B2B publication covering the global pharmaceutical industry, including interviews with industry leaders, country features, and market access coverage. It is a like-for-like peer to PharmaBoardroom in editorial format and audience, though it is UK-anchored and more focused on European news.
- Pharmaceutical Executive: Pharmaceutical Executive is a B2B magazine and digital publication serving senior pharma executives with strategy, policy, and market access content. It targets a similar C-suite audience as PharmaBoardroom and competes for the same executive attention and sponsorship dollars.
Others
- PharmaBoardroom's direct/adjacent - Focus Reports (legacy sister brand context): Focus Reports appears to share the PharmaBoardroom newsletter infrastructure and content lineage, covering country reports and pharma market analysis. It is a closely related publishing/insights brand rather than a direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Pharma Boardroom social profiles
Digital presencePharma Boardroom financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharma Boardroom leadership team
Management profileNumber of profiles
Profiles4 records
Pharma Boardroom funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharma Boardroom M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharma Boardroom
What does Pharma Boardroom do?
PharmaBoardroom produces and sells subscription-based market intelligence for the global pharmaceutical and life sciences industry. Its portfolio includes Country Reports, exclusive executive interviews, The Pharma Legal Handbook series, Market Access & HTA Reports, InFigures statistical datasets, and InFocus e-books covering therapeutic areas and regional market trends across 100+ countries. Premium content is gated behind paid membership, with individual reports and handbooks also sold via a Shopify storefront.
Is Pharma Boardroom a public or private company?
Pharma Boardroom is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Pharma Boardroom founded?
Pharma Boardroom was founded in 2012. It employs 11 to 50 people.
Where is Pharma Boardroom based?
Pharma Boardroom is headquartered in Norwich, United Kingdom, in the Europe region.
How does Pharma Boardroom make money?
Two revenue lines are on record. Subscription Membership is the primary driver. The others are report Sales.
Who are Pharma Boardroom's main competitors?
Broad incumbents on record are FiercePharma, Citeline (Informa Pharma Intelligence), GlobalData Healthcare, The Pink Sheet (Citeline) and Pharma Intelligence / Scrip. Direct peers are BioPharma Dive, Endpoints News, PharmaTimes and Pharmaceutical Executive. PharmaBoardroom's direct/adjacent - Focus Reports (legacy sister brand context) is listed as an others.
Does Pharma Boardroom have an API?
No public API is recorded for Pharma Boardroom.
What industry is Pharma Boardroom in?
Pharma Boardroom's product category is Pharmaceutical Market Intelligence. Its primary akta.pro industry code is HLAIAKAK, Pricing Operations & Analytics (Price Governance, Systems, Reporting). Its NAICS code is 5131 and its SIC code is 2731.